More recently, CXCR4 expression has been used as a marker and potential therapeutic target in adrenal cancer (94), as well as for clinical diagnostic imaging of aldosterone-secreting adenomas using 68Ga-pentixafor PET/CT (95). Here, CXCR4 is linked to adenoma.